(Q43081278)

English

Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia

scientific article published on 29 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 November 2017

Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia (English)

1 reference

Europe PubMed Central

13 November 2017

1 reference

based on heuristic

inferred from title

Chronic graft versus host disease

0 references

author name string

H Nakasone

1

1 reference

Europe PubMed Central

13 November 2017

Y Kanda

2

1 reference

Europe PubMed Central

13 November 2017

H Takasaki

3

1 reference

Europe PubMed Central

13 November 2017

C Nakaseko

4

1 reference

Europe PubMed Central

13 November 2017

T Sakura

5

1 reference

Europe PubMed Central

13 November 2017

S Fujisawa

6

1 reference

Europe PubMed Central

13 November 2017

A Yokota

7

1 reference

Europe PubMed Central

13 November 2017

S Yano

8

1 reference

Europe PubMed Central

13 November 2017

K Usuki

9

1 reference

Europe PubMed Central

13 November 2017

A Maruta

10

1 reference

Europe PubMed Central

13 November 2017

D Abe

11

1 reference

Europe PubMed Central

13 November 2017

T Hoshino

12

1 reference

Europe PubMed Central

13 November 2017

S Takahashi

13

1 reference

Europe PubMed Central

13 November 2017

H Kanamori

14

1 reference

Europe PubMed Central

13 November 2017

S Okamoto

15

1 reference

Europe PubMed Central

13 November 2017

Kanto Study Group for Cell Therapy

16

1 reference

Europe PubMed Central

13 November 2017

publication date

29 April 2010

1 reference

Europe PubMed Central

13 November 2017

1 reference

Europe PubMed Central

13 November 2017

24

1 reference

Europe PubMed Central

13 November 2017

6

1 reference

Europe PubMed Central

13 November 2017

1236-1239

1 reference

Europe PubMed Central

13 November 2017

https://scigraph.springernature.com/pub.10.1038/leu.2010.83

0 references

TGF- in allogeneic stem cell transplantation: friend or foe?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.83

21 January 2018

Platelet-derived growth factor, transforming growth factor-beta, and connective tissue growth factor in a porcine bronchial model of obliterative bronchiolitis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.83

21 January 2018

Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.83

21 January 2018

Imatinib for refractory chronic graft-versus-host disease with fibrotic features.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.83

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.83

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.83

21 January 2018

Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.83

21 January 2018

Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.83

21 January 2018

Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.83

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.83

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2010.83

1 reference

Europe PubMed Central

13 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43081278&oldid=1980476676"